Between 2023 and 2032, the market for Cannabis Inhaler is anticipated to expand at a CAGR of 7.2%.

Increased usage and adoption of cannabis therapy:

Cannabis sativa, generally known as the cannabis plant, contains cannabinoids, a naturally occurring chemical.

In addition to the health hazards associated with cannabis consumption, limited and closely supervised doses of these cannabinoids may be helpful for those with COPD and asthma. This is because the psychoactive cannabidiol drug has bronchodilation effects in humans.

Access the sample report:

Cannabinoids and terpenes are released as a vapor by inhalers used to treat asthma. These inhaled chemicals enter the lungs’ alveoli directly and travel throughout the body via the bloodstream.

The chemicals are made much more bioavailable because of their direct entry into the bloodstream. Due to this and the therapeutic benefits of cannabis, researchers are working to improve these inhalers’ potential medical uses.

The key players of the Global Cannabis Inhaler Market are:

List of the key players profiled in the cannabis inhaler market includes Vapen Brands, CBD Luxe, Fairwinds Cannabis, Koi CBD, H&T Presspart Manufacturing Ltd., MUV, Syqe Medical Ltd., Monarch Life Sciences LLC, Vectura Group plc and Cannabis Inhaler Market Includes.

The cannabis inhalers will show increased growth due to higher adoption:

The industry is now observing certain significant trends, such as the higher efficacy of cannabis, the legalization of cannabis in many nations throughout the world, and an increase in research and development efforts.

During the historic period of the reporting, the asthma section generated enormous revenue. A serious potential lung condition called asthma can enlarge and inflame airways.

Difficulty breathing, chest tightness, and wheezing are possible side effects. Some asthma symptoms can be relieved by bronchodilators because they help loosen the muscles that constrict the airways.

Because cannabis has good biocompatibility and is now legal in many countries, the market for cannabis inhalers is anticipated to grow soon.

Many research programs have been financed to find additional uses for cannabis that might assist treat various conditions, and there is an increase in government measures to support the secure and monitored use of cannabis inhalers.

Read more about the report inclusions:

Global Cannabis Inhaler Market Key Segments:

By Application,

  • Asthma segment
  • Wheezing
  • Tightness in chest
  • Others

Geographical outlook

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Regional performance of Cannabis Inhaler Market

Although marijuana use for both medical and recreational uses is permitted in 36 US states, it is still illegal under federal law because of its lingering adverse effects. The growth of the cannabis inhalers industry in the United States of America has been greatly aided by the legalization of marijuana on a state level.

Only registered medical professionals are permitted to prescribe cannabis to their patients in the UK, Germany, and Cyprus, where it is recognized as a prescription-only medicinal product.

A number of nations, including Germany, Estonia, Netherlands, etc., have outlawed cannabis completely. This demonstrates the market’s sporadic adoption of cannabis inhalers throughout Europe.

However, during the projection period, North America is expected to see extremely high demand. Cannabis is illegal because of prolonged effects that, if not adequately controlled, can lead to addiction. According to federal law, it is still prohibited to buy and use cannabis in the US.

On a state and local level, nevertheless, 36 US states have passed laws permitting the use of cannabis for both medical and recreational uses in regulated environments. This is an important step toward giving cannabis legal recognition, and it will put the American market for cannabis inhalers on the map.

Hindering factors for growth of Cannabis Inhaler Market

The COVID-19 epidemic was a major setback for the cannabis inhaler business since there were a number of phony medications, which reduced public faith in the medical field and negatively impacted sales of cannabis inhalers.

Due to its negative consequences, including its strong addiction, cannabis is illegal in the majority of nations. However, under the regulations and guidelines established by the government, Cannabis is allowed for both therapeutic and recreational use throughout 36 US states.

Proceed to purchase:

Cannabinoids are naturally occurring substances that are easily detected in the Cannabis Sativa plant or cannabis stevia.

Apart from their negative health consequences on people, cannabis inhalers are projected to become more popular soon since, when used properly and under close supervision, cannabinoids can help treat respiratory disorders like asthma and COPD.

The cannabis inhaler market’s profit margins may be restricted by the lack of knowledge regarding the long-term safety of cannabis utilized medicinally.

The market for cannabis inhalers, however, may benefit from the government’s activities and increased regulatory perspective. Asthma is a serious lung condition that can be dangerous. During the projection period, the asthma sector created enormous profits and controlled the market.

Coverage of important statistics in our Cannabis Inhalers Market Report:

This report uses SWOT analysis, which stands for Strengths, Weaknesses, Opportunities, and Threats of the Business, to give an in-depth assessment of the “Cannabis Inhalers Market.”

The Cannabis Inhalers Market Report also offers a comprehensive analysis of the leading market participants based on their profiles, product descriptions, number of products, input materials requirements, and financial standing.

Related reports:

Global Cardiac Stimulant Market:

Global Artificial Blood Pump Market:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at [email protected].

Contact us:

Alex R

+1 707 736 6633

[email protected]

Linkedin | Twitter

Source link